文献速递功能神经外科

微血管减压术治疗药物难治性三叉神经痛的疼痛结局:系统综述与Meta分析

Pain Outcomes Following Microvascular Decompression for Drug-Resistant Trigeminal Neuralgia: A Systematic Review and Meta-Analysis.
PubMed 文献 · Neurosurgery · 2020-01-01

该研究遵循PRISMA指南,检索1988年至2018年3月PubMed、Cochrane Library和Scopus中关于微血管减压术(MVD)治疗三叉神经痛(TN)疼痛结局的原始研究,纳入46项研究共3897例患者。结果显示,MVD术后平均随访1.7±1.3年时,76.0%的患者达到无痛。Meta分析表明,病程≤5年、动脉压迫、小脑上动脉受累及Burchiel 1型分类可能预测更有利的结局。

要点

  • MVD术后平均随访1.7±1.3年,76.0%的药物难治性TN患者达到无痛。
  • 病程≤5年(OR=2.06)、动脉压迫(OR=3.35)、小脑上动脉受累(OR=2.02)及Burchiel 1型(OR=2.49)与无痛相关。
  • 上述结果可能改善患者选择与医生预期。

核心结论

  • 约四分之三的药物难治性TN患者接受MVD后达到无痛。
  • 病程较短、动脉压迫及Burchiel 1型分类可能预测更有利的结局。

研究设计与样本

  • 遵循PRISMA指南的系统综述与Meta分析,检索PubMed、Cochrane Library和Scopus,纳入1988年至2018年3月发表的原始研究。
  • 共纳入46项研究(7项前瞻性,39项回顾性),合计3897例患者,评估潜在偏倚。

主要发现

  • 总体76.0%的患者在平均随访1.7±1.3年时达到无痛(Barrow Neurological Institute评分1)。
  • 随机效应模型Meta分析显示,病程≤5年(OR=2.06,95%CI=1.08-3.95)、动脉压迫(OR=3.35,95%CI=1.91-5.88)、小脑上动脉受累(OR=2.02,95%CI=1.02-4.03)及Burchiel 1型分类(OR=2.49,95%CI=1.32-4.67)与无痛相关。

关键数值与推荐

  • 主要结局指标为末次随访时无痛(Barrow Neurological Institute评分1)。
  • 初步分析中与无痛相关的变量进行正式Meta分析,计算比值比(OR)及95%置信区间(CI)。

临床怎么用

  • MVD可使约四分之三的药物难治性TN患者达到无痛。
  • 病程≤5年、动脉压迫、小脑上动脉受累及Burchiel 1型分类可能有助于患者选择与预期管理。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microvascular decompression (MVD) is a potentially curative surgery for drug-resistant trigeminal neuralgia (TN). Predictors of pain freedom after MVD are not fully understood. OBJECTIVE: To describe rates and predictors for pain freedom following MVD. METHODS: Using preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, PubMed, Cochrane Library, and Scopus were queried for primary studies examining pain outcomes after MVD for TN published between 1988 and March 2018. Potential biases were assessed for included studies. Pain freedom (ie, Barrow Neurological Institute score of 1) at last follow-up was the primary outcome measure. Variables associated with pain freedom on preliminary analysis underwent formal meta-analysis. Odds ratios (OR) and 95% confidence intervals (CI) were calculated for possible predictors. RESULTS: Outcome data were analyzed for 3897 patients from 46 studies (7 prospective, 39 retrospective). Overall, 76.0% of patients achieved pain freedom after MVD with a mean follow-up of 1.7 ± 1.3 (standard deviation) yr. Predictors of pain freedom on meta-analysis using random effects models included (1) disease duration ≤5 yr (OR = 2.06, 95% CI = 1.08-3.95); (2) arterial compression over venous or other (OR = 3.35, 95% CI = 1.91-5.88); (3) superior cerebellar artery involvement (OR = 2.02, 95% CI = 1.02-4.03), and (4) type 1 Burchiel classification (OR = 2.49, 95% CI = 1.32-4.67). CONCLUSION: Approximately three-quarters of patients with drug-resistant TN achieve pain freedom after MVD. Shorter disease duration, arterial compression, and type 1 Burchiel classification may predict more favorable outcome. These results may improve patient selection and provider expectations.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Holste K, Chan AY, Rolston JD, et al. Pain Outcomes Following Microvascular Decompression for Drug-Resistant Trigeminal Neuralgia: A Systematic Review and Meta-Analysis. Neurosurgery. 2020. PMID: 30892607. doi:10.1093/neuros/nyz075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。